DMPHF(DMPHF)
DMPHF
No analyst ratings available
No analyst price targets available for DMPHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.20B | $1.25B | $1.30B | $1.35B |
| Low | $1.19B | $1.24B | $1.28B | $1.33B |
| High | $1.23B | $1.27B | $1.32B | $1.37B |
| EBITDA Avg | $352M | $365M | $379M | $395M |
| Low | $348M | $362M | $376M | $391M |
| High | $359M | $372M | $387M | $402M |
| EBIT Avg | $257M | $267M | $277M | $288M |
| Low | $254M | $264M | $274M | $285M |
| High | $262M | $271M | $282M | $294M |
| Net Income Avg | $142M | $157M | $171M | $182M |
| Low | $141M | $155M | $169M | $179M |
| High | $146M | $161M | $175M | $186M |
| EPS Avg | $2.65 | $2.92 | $3.17 | $3.37 |
| Low | $2.61 | $2.88 | $3.13 | $3.33 |
| High | $2.71 | $2.99 | $3.25 | $3.46 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 2 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $305M | $305M |
| Low | $305M | $305M |
| High | $305M | $305M |
| EBITDA Avg | $89M | $89M |
| Low | $89M | $89M |
| High | $89M | $89M |
| EBIT Avg | $65M | $65M |
| Low | $65M | $65M |
| High | $65M | $65M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |